These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 10915729)

  • 1. Natural history of inoperable hepatocellular carcinoma: estrogen receptors' status in the tumor is the strongest prognostic factor for survival.
    Villa E; Moles A; Ferretti I; Buttafoco P; Grottola A; Del Buono M; De Santis M; Manenti F
    Hepatology; 2000 Aug; 32(2):233-8. PubMed ID: 10915729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormonal therapy with megestrol in inoperable hepatocellular carcinoma characterized by variant oestrogen receptors.
    Villa E; Ferretti I; Grottola A; Buttafoco P; Buono MG; Giannini F; Manno M; Bertani H; Dugani A; Manenti F
    Br J Cancer; 2001 Apr; 84(7):881-5. PubMed ID: 11286465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variant liver estrogen receptor transcripts already occur at an early stage of chronic liver disease.
    Villa E; Dugani A; Moles A; Camellini L; Grottola A; Buttafoco P; Merighi A; Ferretti I; Esposito P; Miglioli L; Bagni A; Troisi R; De Hemptinne B; Praet M; Callea F; Manenti F
    Hepatology; 1998 Apr; 27(4):983-8. PubMed ID: 9537437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic values of alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II in hepatitis B virus-related hepatocellular carcinoma: a prospective study.
    Kim HS; Park JW; Jang JS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Jang MK
    J Clin Gastroenterol; 2009; 43(5):482-8. PubMed ID: 19197197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of tumor pressure as a prognostic factor in cases of hepatocellular carcinoma where the diameter of the tumor is 3 cm or less.
    Ueki T; Sakaguchi S; Miyajima Y; Hatono N; Tohara K; Nakabayashi S; Yao T; Kokawa H; Hirano M; Okumura M
    Cancer; 2002 Aug; 95(3):596-604. PubMed ID: 12209753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors after hepatic resection for hepatocellular carcinoma with hepatitis C viral infection: univariate and multivariate analysis.
    Hanazaki K; Kajikawa S; Koide N; Adachi W; Amano J
    Am J Gastroenterol; 2001 Apr; 96(4):1243-50. PubMed ID: 11316177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical and pathogenetic significance of estrogen receptor-beta expression in chronic liver diseases and liver carcinoma.
    Iavarone M; Lampertico P; Seletti C; Francesca Donato M; Ronchi G; del Ninno E; Colombo M
    Cancer; 2003 Aug; 98(3):529-34. PubMed ID: 12879470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment and prognostic factors in patients with hepatocellular carcinoma.
    Martins A; Cortez-Pinto H; Marques-Vidal P; Mendes N; Silva S; Fatela N; Glória H; Marinho R; Távora I; Ramalho F; de Moura MC
    Liver Int; 2006 Aug; 26(6):680-7. PubMed ID: 16842324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors influencing survival in hepatocellular carcinoma patients with macroscopic portal vein tumor thrombosis after surgery, with special reference to time dependency: a single-center experience of 381 cases.
    Zhou J; Tang ZY; Wu ZQ; Zhou XD; Ma ZC; Tan CJ; Shi YH; Yu Y; Qiu SJ; Fan J
    Hepatogastroenterology; 2006; 53(68):275-80. PubMed ID: 16608039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic index for patients with hepatocellular carcinoma combined with tumor thrombosis in the major portal vein.
    Ikai I; Hatano E; Hasegawa S; Fujii H; Taura K; Uyama N; Shimahara Y
    J Am Coll Surg; 2006 Mar; 202(3):431-8. PubMed ID: 16500247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Liver transplantation for hepatocellular carcinoma: prognostic analysis of 89 cases].
    Zheng SS; Xu X; Liang TB; Wang WL; Shen Y; Zhang M; Wu J; Lu AW; Shao ZX
    Zhonghua Wai Ke Za Zhi; 2005 Apr; 43(7):450-4. PubMed ID: 15854372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the clinical characteristics among hepatocellular carcinoma of hepatitis B, hepatitis C and non-B non-C patients.
    Dohmen K; Shigematsu H; Irie K; Ishibashi H
    Hepatogastroenterology; 2003; 50(54):2022-7. PubMed ID: 14696457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors for long-term outcome after percutaneous thermal ablation for hepatocellular carcinoma: a survival analysis of 137 consecutive patients.
    Xu HX; Lu MD; Xie XY; Yin XY; Kuang M; Chen JW; Xu ZF; Liu GJ
    Clin Radiol; 2005 Sep; 60(9):1018-25. PubMed ID: 16124984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics and prognosis of hepatocellular carcinoma patients with paraneoplastic syndromes.
    Luo JC; Hwang SJ; Wu JC; Lai CR; Li CP; Chang FY; Chiang JH; Lui WY; Chu CW; Lee SD
    Hepatogastroenterology; 2002; 49(47):1315-9. PubMed ID: 12239934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AFP mRNA detected in bone marrow by real-time quantitative RT-PCR analysis predicts survival and recurrence after curative hepatectomy for hepatocellular carcinoma.
    Kamiyama T; Takahashi M; Nakagawa T; Nakanishi K; Kamachi H; Suzuki T; Shimamura T; Taniguchi M; Ozaki M; Matsushita M; Furukawa H; Todo S
    Ann Surg; 2006 Sep; 244(3):451-63. PubMed ID: 16926571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different prognostic value of cytokeratin-19 mRNA positive circulating tumor cells according to estrogen receptor and HER2 status in early-stage breast cancer.
    Ignatiadis M; Xenidis N; Perraki M; Apostolaki S; Politaki E; Kafousi M; Stathopoulos EN; Stathopoulou A; Lianidou E; Chlouverakis G; Sotiriou C; Georgoulias V; Mavroudis D
    J Clin Oncol; 2007 Nov; 25(33):5194-202. PubMed ID: 17954712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Risk factors for early recurrence after surgical resection for hepatocellular carcinoma].
    Park UJ; Kim YH; Kang KJ; Lim TJ
    Korean J Hepatol; 2008 Sep; 14(3):371-80. PubMed ID: 18815460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A comparison of patients with hepatocellular carcinoma between a short-term (less than 6 months) survival group and a long-term (over 24 months) survival group after treatment with transcatheter arterial chemoembolization].
    Kang IK; Kim SW; Hahn SH; Cho SC; Gham CW; Lee DH
    Taehan Kan Hakhoe Chi; 2002 Jun; 8(2):189-200. PubMed ID: 12499805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of prognostic factors on the outcome of liver transplantation for hepatocellular carcinoma on cirrhosis: a univariate and multivariate analysis.
    Del Gaudio M; Grazi GL; Principe A; Ravaioli M; Ercolani G; Cescon M; Varotti G; Gardini A; Cavallari A
    Hepatogastroenterology; 2004; 51(56):510-4. PubMed ID: 15086193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical appraisal of the clinical and pathologic predictors of survival after resection of large hepatocellular carcinoma.
    Pawlik TM; Poon RT; Abdalla EK; Zorzi D; Ikai I; Curley SA; Nagorney DM; Belghiti J; Ng IO; Yamaoka Y; Lauwers GY; Vauthey JN;
    Arch Surg; 2005 May; 140(5):450-7; discussion 457-8. PubMed ID: 15897440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.